Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management

医学 慢性荨麻疹 血管性水肿 奥马佐单抗 指南 重症监护医学 疾病 生活质量(医疗保健) 梅德林 皮肤病科 免疫学 病理 免疫球蛋白E 法学 抗体 护理部 政治学
作者
Liting He,Wanyu Yi,Xin Huang,Hai Long,Qianjin Lu
出处
期刊:Clinical Reviews in Allergy & Immunology [Springer Nature]
卷期号:61 (3): 424-448 被引量:49
标识
DOI:10.1007/s12016-021-08886-x
摘要

Chronic urticaria (CU) is a common skin condition characterized by the recurrence of wheals, with or without angioedema, which lasts for at least 6 weeks. Owing to its pruritus and incurability, this disease adversely affects the patients' physical and mental health and diminishes the quality of life. CU is generally classified into two subtypes based on the relevance of eliciting factors: chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU), the latter of which is further divided into several subtypes. To improve the understanding and clinical management of this highly heterogeneous disorder, the EAACI/GA2LEN/EDF/WAO guideline was developed and published in 2018 based on evidence and expert consensus. The diagnostic and treatment algorithms proposed by the guideline have largely facilitated dermatologists in clinical practice. However, several questions remained unsolved and have been widely investigated in the recent years. First, a better understanding of the association between chronic urticaria and its potential underlying causes or eliciting factors such as autoimmunity, infections, coagulation aberrance, and vitamin D deficiency is warranted. This would lead to updates in the diagnostic and treatment procedures of different subtypes of chronic urticaria. Secondly, treatment for recalcitrant cases, especially those resistant to or intolerant of second-generation antihistamines and (or) omalizumab, calls for novel therapeutic measures or strategies. In the present review, we summarized recent advances in the understanding and management of both CSU and CIndU, with special emphasis on their underlying causes or eliciting factors, pathogenic mechanisms, potential targets for intervention, and advances in treatment strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
AliciaJF完成签到,获得积分20
刚刚
英俊的铭应助拉拉王采纳,获得10
1秒前
2秒前
nn666发布了新的文献求助10
3秒前
3秒前
东郭一斩完成签到,获得积分10
3秒前
you完成签到 ,获得积分10
5秒前
一笙完成签到,获得积分20
5秒前
戴玥发布了新的文献求助10
5秒前
6秒前
7秒前
李健应助晚心采纳,获得10
7秒前
小二郎应助kai采纳,获得10
8秒前
Aniee完成签到,获得积分10
9秒前
龙卷风发布了新的文献求助10
9秒前
10秒前
conny完成签到,获得积分10
11秒前
11秒前
wzjs发布了新的文献求助10
11秒前
sssssssssss完成签到,获得积分10
12秒前
Glufo发布了新的文献求助10
12秒前
JamesPei应助ichris采纳,获得10
14秒前
充电宝应助nn666采纳,获得10
14秒前
Hello应助charm12采纳,获得10
14秒前
漂亮灵阳完成签到,获得积分10
15秒前
hode发布了新的文献求助10
15秒前
15秒前
16秒前
Ashui发布了新的文献求助10
16秒前
17秒前
慕青应助sssssssssss采纳,获得10
17秒前
lulu完成签到,获得积分20
18秒前
Yziii应助毛毛采纳,获得20
19秒前
无情的菲鹰完成签到 ,获得积分10
19秒前
自由自在的飞翔完成签到,获得积分10
20秒前
Clover04发布了新的文献求助10
20秒前
20秒前
21秒前
21秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Very-high-order BVD Schemes Using β-variable THINC Method 870
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Fundamentals of Dispersed Multiphase Flows 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3254506
求助须知:如何正确求助?哪些是违规求助? 2896643
关于积分的说明 8293717
捐赠科研通 2565614
什么是DOI,文献DOI怎么找? 1393195
科研通“疑难数据库(出版商)”最低求助积分说明 652443
邀请新用户注册赠送积分活动 629992